Spignoli G, Pepeu G. Oxiracetam prevents electroshock- induced decrease in brain acetylcholine and amnesia [J]. European Journal of Pharmacology, 1986, 126 (3): 253- 257.
[2]
Saletu B, Linzmayer L, Grünberger J, Pietschmann H. Double-blind, placebo-controlled, clinical, psychometric and neurophysiological investigations with oxiracetam in the organic brain syndrome of late life [J]. Neuropsychobiology, 1985, 13 (1/2): 44-52.
[3]
Ye Lei. (S)-4-hydroxy-2-oxo-1-pyrrolidineacetamide racemate crystal form ii and preparation method therefor [P]: US, 14/237894. 2012-4-24.
[4]
Iriuchijima S, Kobayashi H, Aoki K, et al. Process for producing oxiracetam [P]: U.S, 4686296. 1987-8-11.
[5]
Wang Z Z, Chen J M, Lu T B. Enhancing the hygroscopic stability of S-oxiracetam via pharmaceutical cocrystals [J]. Crystal Growth & Design, 2012, 12(9): 4562-4566.
[6]
Mellor J D. Fundamentals of Freeze-Drying [M]. London: Academic Press Inc. Ltd., 1978.
[7]
Pikal M J. Freeze-drying of proteins. Process, formulation, and stability [J]. ChemInform, 1995, 26(4). DOI: 10.1002/chin.199504315.
[8]
Liapis A I, Pim M L, Bruttini R. Research and development needs and opportunities in freeze drying [J]. Drying Technology, 1996, 14 (6): 1265-1300.
[9]
Yu Jianping, Liu J H, Pu L Q, Cui Xiangdong, Wang Changzheng, Ouyang S L, Gao Dayong. Freeze-drying of human red blood cells: influence of carbohydrates and their concentrations [J]. Cell Preservation Technology, 2004, 2 (4): 270-275.
[10]
Zhou Xinli (周新丽), Liu Jianfeng (刘建峰), Zhang Shaozhi (张绍志), Chen Guangming (陈光明). Thermal analysis on lyoprotectants for biomaterials [J] Journal of Refrigeration (制冷学报), 2008, 29 (5): 54-57.
[11]
Wang Jingkang (王静康). Crystallization (结晶)//Shi Jun (时钧), Wang Jiading (汪家鼎), Yu Kuo Tsung (余国琮), Chen Minheng (陈敏恒). Handbook of Chemical Engineering (化学工程手册) [M]. Beijing: Chemical Industry Press. 1996.
Liu H, Lelièvre J. Transitions in frozen gelatinized-starch systems studied by differential scanning calorimetry [J]. Carbohydrate Polymers, 1992, 19 (3): 179-183.
[14]
Varshney D B, Kumar S, Shalaev E Y, Kang S W, Gatlin L A, Suryanarayanan R. Solute crystallization in frozen systems-use of synchrotron radiation to improve sensitivity [J]. Pharmaceutical Research, 2006, 23 (10): 2368-2374.
[15]
Zhu Liang(朱亮). Effects of pre-freeze in the freeze drying process [J]. Drying Technology & Equipment (干燥技术与设备), 2014, 12 (1): 32-34.
[16]
López-Urue？a E, Alvarez M, Gomes-Alves S, et al. Tolerance of brown bear spermatozoa to conditions of pre-freezing cooling rate and equilibration time [J]. Theriogenology, 2014, 81 (9): 1229-1238.
[17]
Gao Zhifeng(高志峰). A freeze-dried powder and preparation method of oxiracetam [P]: CN, 102274195 A. 2011-07-18.
[18]
Yani Y, Chow P S, Tan R B H. Molecular simulation study of the effect of various additives on salbutamol sulfate crystal habi [J]. Molecular pharmaceutics, 2011, 8 (5): 1910-1918.
[19]
Schmidt C, Ulrich J. Morphology prediction of crystals grown in the presence of impurities and solvents-an evaluation of the state of the art [J]. Journal of Crystal Growth, 2012, 353 (1): 168-173.
[20]
Gupta P, Thilagavathi R, Chakraborti A K, Bansal A K. Role of molecular interaction in stability of celecoxib-PVP amorphous systems [J]. Molecular Pharmaceutics, 2005, 2 (5): 384-391.
[21]
Belfiore P, Ponzio F, Biagetti R, Berettera C, Magnani M, Pozzi O. Oxiracetam prevents the hippocampal cholinergic hypofunction induced by the NMDA receptor blocker AP7 [J]. Neuroscience Letters, 1992, 143 (1): 127-130.
